Questioning the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
This study demonstrates the efficacy of ambulatory blood pressure monitoring to measure antihypertensive effect. Original Article: White WB, Giles T, Bakris GL, Neutel JM, Davidai G, Weber MA. Measuring the efficacy of anti hypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. Am Heart J. 2006;151(1):176-184.
Dawes
Martin
M
McGill University, Montreal, Quebec H2W1S4, Canada. martin.dawes@mcgill.ca
D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D018660:Blood Pressure Monitoring, Ambulatory; D017327:Clinical Trials, Phase IV as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care; D011446:Prospective Studies; D000077333:Telmisartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D000077333:Telmisartan